KALA Bio stock plunges 92% after KPI-012 phase 2 trial failure.
https://seekingalpha.com/news/4499819-kala-bio-plunges-92-after-phase-2-failure-eye-condition-drug
KALA Bio stock plunges 92% after KPI-012 phase 2 trial failure.
https://seekingalpha.com/news/4499819-kala-bio-plunges-92-after-phase-2-failure-eye-condition-drug
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.